Preparing to Pivot: Managing the November Hemp Ban
The cooler door at a national grocery chain still holds rows of hemp-derived THC beverages. Five-milligram cans next to seltzer. Microdose six-packs next to non-alc beer. A category that did not exist at scale four years ago now generates more than $1 billion in annual U.S. sales.
On November 12, 2026, most of what sits in that cooler becomes federally unlawful.
The mechanism is Section 781 of the Continuing Appropriations Act for 2026, signed last November with a one-year runway. The runway is most of the way gone. Operators who have not modeled the post-ban business in detail are running out of time to do so. The ones who have are now executing against the model.
This piece is for the operators still working through what to do. The ban is not a single problem; it is four distinct ones, and they have to be solved in parallel.
What the ban actually does
Most public commentary collapses Section 781 into "the hemp ban." Inside the operator chair, there are four distinct provisions to plan against, and each one breaks a different part of the business.
The dose cap. The statute caps finished hemp-derived cannabinoid products at 0.4 milligrams of total THC per container. A standard 5mg THC beverage exceeds that by twelve and a half times. A 10mg can exceeds it by twenty-five. There is no version of an existing hemp THC beverage that complies with this number without a fundamental product change.
The total THC standard. The federal definition of hemp shifts from delta-9 THC alone to total THC, including THCA and other isomers. This closes the loophole that allowed high-THCA derivatives to ride under a delta-9 threshold. For beverage operators, the practical effect is that the math on raw material sourcing tightens before the finished product limit even applies.
The synthetic and converted exclusion. Cannabinoids that are not capable of being naturally produced by the cannabis plant, or that were synthesized or manufactured outside the plant, are excluded from the hemp definition. Most delta-8 in the market is produced by converting CBD through an acid-catalyzed reaction, which is now out. So is HHC. Operators whose product stacks rely on converted cannabinoids are on a separate, faster timeline than those using naturally derived delta-9.
The implementation gap. The FDA was required to publish three cannabinoid lists and a working definition of "container" by February 10, 2026, and missed the deadline. As of early summer, the guidance still has not been issued. Operators have to plan against the statute itself, not against agency clarification that may or may not arrive before enforcement begins. States are not waiting either: Ohio enacted a categorical ban in December 2025, New Jersey is channeling THC beverages into its licensed cannabis framework, and Texas adopted total THC rules effective March 31, 2026. Each of these moves shifts the operator's channel map independently of the federal date.
Reformulation: the math, then the path
The first instinct in most operator conversations is to look for a compliant version of the existing product. That instinct burns time. A 0.4mg-per-container cap is not a reformulation problem; it is a category problem. At that threshold, no perceptible THC effect is possible from a single unit (for most consumers). A product engineered to meet the cap and still deliver an intoxicating dose would require consumers to drink twelve or more containers to approach a standard serving, which is neither a viable consumer experience nor a sustainable retail proposition.
There are three honest paths, and a credible advisor will say so plainly.
The first is reformulation into a non-intoxicating functional beverage. Adaptogens, nootropics, mushroom extracts, CBD isolate at meaningful but non-intoxicating concentrations, and other plant- and fungi-based actives can carry a functional benefit claim without touching the THC threshold. This path keeps existing retail relationships, distribution footprint, and most of the brand equity intact. It loses the THC consumer; whether that loss is recoverable depends on whether the brand was sold primarily on the cannabinoid or on the broader functional positioning.
The second is migration into licensed cannabis channels on a state-by-state basis. New Jersey is structurally inviting this path, and several adult-use states will tolerate it de facto for compliant products. The cost is real. Licensed cannabis distribution carries higher tax, higher compliance load, narrower retail (dispensaries, not grocery), and a fragmented multi-state operator model that does not scale the way a hemp DSD route does. Brands built on cooler placement do not transplant cleanly onto dispensary shelves.
The third is exit, partial or full. For some product lines, particularly those built on converted cannabinoids, exit is not a strategic choice; it is the only available one. Operators who recognize that early can redirect capital and team capacity before more of either gets spent defending a position that will not hold.
The right path depends on three variables: how much of current revenue is hemp THC versus other lines, how durable the brand equity is outside the cannabinoid, and how much working capital is available to fund a parallel build into licensed channels. There is no universal answer, but there is a disciplined process to arrive at the right one.
Supply chain, inventory, and contracts
The operational work runs on a shorter clock than the strategic work. Three areas need immediate attention.
Inventory and forward orders should be modeled against a clear sell-through assumption. The reasonable planning case is a consumer pull-forward in the months leading to November 12, similar to what was observed in state-level pre-ban windows. The aggressive case is meaningful retail destocking earlier than expected, as chains move to limit shelf risk. Both cases need to be modeled, with the inventory plan sized to the more conservative of the two.
Co-packer and raw material commitments should be reviewed for change-in-law clauses, termination rights, and inventory pass-through obligations. Most beverage co-packer agreements were drafted before this provision existed. The contractual position an operator has today is not necessarily the contractual position the operator wants by the fall.
Distribution and retail contracts need the same review. Slotting, MCBs, and chargeback exposure on discontinued SKUs can compound quickly. A direct conversation with the top three retail partners about the transition timeline is more valuable than three more months of internal modeling.
Channel strategy as the federal map fragments
The most underdiscussed operator decision is geographic. Federal preemption is not in play here; states are moving in different directions, and the right post-November channel map will look unrecognizable to the pre-ban one.
Ohio's SB 56 is the categorical-ban model: out is out, no licensed cannabis off-ramp for hemp beverage operators. New Jersey is the channel-shift model: compliant products flow into the licensed cannabis framework, which preserves market access for operators willing to take on the compliance load. Texas adopted total THC rules ahead of the federal date, which functionally previews the federal regime in one of the largest hemp markets. Each of these requires a different operator response, and the right portfolio of state responses depends on where current volume sits.
The practical move is a state-level revenue map against three categories: states where the current product can continue with state licensure, states where reformulation is the only path, and states where neither is viable on the relevant timeline. That map drives where to invest in compliance build, where to reformulate, and where to step back. It is a more useful planning artifact than a single national strategy.
Advocacy without betting on it
There is real legislative activity in motion. Representative Andy Barr's Lawful Hemp Protection Act contemplates a three-tier distribution model under the TTB and a higher THC threshold for finished products. Representative Nancy Mace's American Hemp Protection Act would strike Section 781 outright. The 2026 Farm Bill reauthorization, due September 30, sits adjacent to the conversation. The midterm elections on November 5 fall one week before the enforcement date.
Engaging this advocacy is the right thing to do. Joining trade associations, communicating with consumers about what is happening, and supporting a regulated alternative to outright prohibition all matter. The framework that eventually emerges, whether before or after November 12, will be shaped in part by which operators showed up to help define it.
The mistake is to treat advocacy as a business strategy. The legislative calendar is not favorable. Even a fix that passes after November 12 leaves a gap during which the existing category is federally unlawful, with all of the inventory, channel, and contractual consequences that follow. A business plan that assumes Congress will solve this in time is operating without a planning horizon. The disciplined posture is to build for the statute as written and treat any legislative relief as upside, not as the base case.
The window that remains
There are roughly five months left before the federal date. That is enough time to execute a reformulation, reposition a brand, build a state-level channel strategy, and renegotiate the contracts that matter, provided the work starts now and the strategic call has already been made.
The operators who come out of November 12 in a defensible position will share three traits. They will have modeled the post-ban business honestly. They will have made the strategic call early enough to execute against it. And they will have built relationships with the regulators and trade groups who will shape what comes next. The category will continue to exist in some form, and the next chapter of its definition will be written by the operators who are still in the room when it is.
Evan Eneman is the founder of CPG and hospitality consulting firm Sands Lane, beverage advisory and operating platform Harmony Craft Beverages, and co-founder and CEO of Iconic Tonics, a functional beverage portfolio in partnership with Snoop Dogg. He has been building at the intersection of culture, content, and commerce in the cannabis and functional wellness space since 2014.
